Miller W - Search Results

1

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Among authors: miller w, miller js. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 Free article.

2

Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia.

Verfaillie C, Kay N, Miller W, McGlave P. Verfaillie C, et al. Among authors: miller w. Blood. 1990 Jul 15;76(2):401-8. Blood. 1990. PMID: 1695114 Free article.

3

Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity.

Verfaillie C, Miller W, Kay N, McGlave P. Verfaillie C, et al. Among authors: miller w. Blood. 1989 Aug 1;74(2):793-7. Blood. 1989. PMID: 2473805 Free article.

4

Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation.

McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NK. McGlave PB, et al. Among authors: miller w. Blood. 1987 Nov;70(5):1325-30. Blood. 1987. PMID: 3311200 Free article.

5

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P. Enright H, et al. Among authors: miller j, miller w. Blood. 1996 Jul 15;88(2):714-20. Blood. 1996. PMID: 8695820 Free article.

6

A new in situ hybridization technique for spliced RNA species documents the bone marrow origin of pulmonary macrophages in chronic myelogenous leukemia.

Ely P, Haase A, Wietgrefe S, Zupancic M, Beneke J, Hertz M, Miller W. Ely P, et al. Among authors: miller w. Blood. 1992 Nov 1;80(9):2321-5. Blood. 1992. PMID: 1421402 Free article.

7

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Weisdorf D, et al. Among authors: miller w. Blood. 1990 Feb 15;75(4):1024-30. Blood. 1990. PMID: 2302454 Free article.

8

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.

Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P. Weisdorf D, et al. Among authors: miller j, miller w. Biol Blood Marrow Transplant. 1997 Oct;3(4):217-23. Biol Blood Marrow Transplant. 1997. PMID: 9360784 Clinical Trial.

9

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.

Miller W, Flynn P, McCullough J, Balfour HH Jr, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J. Miller W, et al. Blood. 1986 Apr;67(4):1162-7. Blood. 1986. PMID: 3006831 Free article.

10

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D. Ochs L, et al. Among authors: miller j, miller w. Blood. 1995 Nov 15;86(10):3979-86. Blood. 1995. PMID: 7579369 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,156 results

Search Page

Filters